Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment Protocol for Young Adults with Acute Lymphoblastic Leukemia
2011-000908-18Phase 3Terminated
- Sponsor
- Vilnius University Hospital Santaros Klinikos
- Start
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of mercaptopurine in acute lymphoblastic leukemia (ALL), sponsored by Vilnius University Hospital Santaros Klinikos. Primary endpoints: Primary: Reduction of relapse rate and Primary: Reduction of residual disease level (MRD). Started Mar 2011; status: terminated.
02
Drugs
mercaptopurine
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on 2011-000908-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000908-18.